Spots Global Cancer Trial Database for epithelial malignancies
Every month we try and update this database with for epithelial malignancies cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal | NCT01341496 | Sarcoma Melanoma Epithelial Mali... Pleural Maligna... | Epigenetically ... Cyclophosphamid... Celecoxib | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal | NCT01341496 | Sarcoma Melanoma Epithelial Mali... Pleural Maligna... | Epigenetically ... Cyclophosphamid... Celecoxib | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum | NCT01313429 | Sarcoma Melanoma Epithelial Mali... Pleural Maligna... | Cyclophosphamid... Allogenic tumor... Celecoxib | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum | NCT01313429 | Sarcoma Melanoma Epithelial Mali... Pleural Maligna... | Cyclophosphamid... Allogenic tumor... Celecoxib | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
Sym013 (Pan-HER) in Patients With Advanced Epithelial Malignancies | NCT02906670 | Oncology | Sym013 | 18 Years - | Symphogen A/S |